-
S109119-25mlSqualene is a biosynthetic precursor for all steroids that is cytoprotective to normal cells exposed to carcinogens and antitumor agentsBiosynthetic precursor to all steroids. Cytoprotective to normal cells exposed to carcinogens and antitumor
-
S109119-500mlSqualene is a biosynthetic precursor for all steroids that is cytoprotective to normal cells exposed to carcinogens and antitumor agentsBiosynthetic precursor to all steroids. Cytoprotective to normal cells exposed to carcinogens and antitumor
-
S109119-5mlSqualene is a biosynthetic precursor for all steroids that is cytoprotective to normal cells exposed to carcinogens and antitumor agentsBiosynthetic precursor to all steroids. Cytoprotective to normal cells exposed to carcinogens and antitumor
-
S167823-100mgSelective VEGFR2 inhibitor.
-
S167823-10mgSelective VEGFR2 inhibitor.
-
S167823-250mgSelective VEGFR2 inhibitor.
-
S167823-25mgSelective VEGFR2 inhibitor.
-
S167823-50mgSelective VEGFR2 inhibitor.
-
S167823-5mgSelective VEGFR2 inhibitor.
-
S125148-100gSulindac (Clinoril) is a non-steroidal anti-inflammatory agent of the arylalkanoic acid class.Treatment of human colorectal cancer cell lines induces MRP1 and MRP3 but not other members of the MRP family. Reported to significantly increase the
-
S125148-1gSulindac (Clinoril) is a non-steroidal anti-inflammatory agent of the arylalkanoic acid class.Treatment of human colorectal cancer cell lines induces MRP1 and MRP3 but not other members of the MRP family. Reported to significantly increase the
-
S125148-25gSulindac (Clinoril) is a non-steroidal anti-inflammatory agent of the arylalkanoic acid class.Treatment of human colorectal cancer cell lines induces MRP1 and MRP3 but not other members of the MRP family. Reported to significantly increase the